Medtronic Wins Approval for Device to Resynchronize Heart

Medtronic Inc. won U.S. regulatory approval for its Viva device used to resynchronize the beating of the heart and reduce hospitalizations for heart failure.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.